Literature DB >> 11165924

Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice.

V Lemos de Souza1, J Ascenção Souza, T M Correia Silva, P Sampaio Tavares Veras, L A Rodrigues de-Freitas.   

Abstract

Most experimental studies on leishmaniasis compare two different inbred strains of mice that are resistant or susceptible to one species of Leishmania. In the present study we characterized some cytokines and nitric oxide production as well as histological changes related to resistance and susceptibility in isogenic CBA mice infected with Leishmania major or Leishmania amazonensis. CBA mice are capable of controlling infection with L. major, but they succumb to infection with L. amazonensis. Cells from susceptible L. amazonensis-infected CBA mice produced interleukin (IL)-4 and IL-10 but no interferon (IFN)-gamma. On the other hand, resistant L. major-infected CBA mice produced IFN-gamma and IL-10, but IL-4 was detected only in the first week of infection. Histopathological studies showed patterns of tissue responses at the site of the infection and in the draining lymph nodes that correlated with resistance or susceptibility. Resistant mice showed a mixed inflammatory cell infiltration and granulomas in the lesions, whereas in susceptible mice only heavily parasitized macrophages were seen. Our results indicate an important role of the parasite species in determining the pattern of immune response. L. amazonensis induces a Th2-type immune response, whereas L. major induces a Th1-type response. These factors must be identified and taken into account in the strategies for the development of vaccines against leishmaniasis. The model presented here will be useful for the study of such factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11165924     DOI: 10.1016/s1286-4579(00)01340-x

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  21 in total

1.  Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.

Authors:  Marta Gontijo Aguiar; Aline Márcia Machado Pereira; Ana Paula Fernandes; Lucas Antonio Miranda Ferreira
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

2.  Multifunctional CD4⁺ T cells in patients with American cutaneous leishmaniasis.

Authors:  A B B Macedo; J C Sánchez-Arcila; A O Schubach; S C F Mendonça; A Marins-Dos-Santos; M de Fatima Madeira; T Gagini; M I F Pimentel; P M De Luca
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

3.  Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-l-cysteine.

Authors:  Etel Rocha-Vieira; Ellen Ferreira; Priscila Vianna; Daniela R De Faria; Soraya T Gaze; Walderez O Dutra; Kenneth J Gollob
Journal:  Immunology       Date:  2003-03       Impact factor: 7.397

4.  Candida-specific antibodies during experimental vaginal candidiasis in mice.

Authors:  Karen L Wozniak; Floyd L Wormley; Paul L Fidel
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Antileishmanial activity of 1,3,4-thiadiazolium-2-aminide in mice infected with Leishmania amazonensis.

Authors:  Raquel F Rodrigues; Karen S Charret; Edson F da Silva; Aurea Echevarria; Verônica F Amaral; Leonor L Leon; Marilene M Canto-Cavalheiro
Journal:  Antimicrob Agents Chemother       Date:  2008-11-17       Impact factor: 5.191

6.  Association between skin parasitism and a granulomatous inflammatory pattern in canine visceral leishmaniosis.

Authors:  Washington L C dos-Santos; John David; Roberto Badaró; Luiz A R de-Freitas
Journal:  Parasitol Res       Date:  2003-11-11       Impact factor: 2.289

7.  Leishmania amazonensis fails to induce the release of reactive oxygen intermediates by CBA macrophages.

Authors:  T F Almeida; L C Palma; L C Mendez; A A Noronha-Dutra; P S T Veras
Journal:  Parasite Immunol       Date:  2012-10       Impact factor: 2.280

8.  Characterization of chronic cutaneous lesions from TNF-receptor-1-deficient mice infected by Leishmania major.

Authors:  Carolina Ferreira Oliveira; Daniel Manzoni-de-Almeida; Paula Seixas Mello; Caio Cotta Natale; Helton da Costa Santiago; Luíza da Silva Miranda; Fernanda Oliveira Ferraz; Liliane Martins dos Santos; Mauro Martins Teixeira; Rosa Maria Esteves Arantes; Leda Quercia Vieira
Journal:  Clin Dev Immunol       Date:  2011-12-08

9.  A comparison of two distinct murine macrophage gene expression profiles in response to Leishmania amazonensis infection.

Authors:  Christian M Probst; Rodrigo A Silva; Juliana P B Menezes; Tais F Almeida; Ivana N Gomes; Andréia C Dallabona; Luiz S Ozaki; Gregory A Buck; Daniela P Pavoni; Marco A Krieger; Patrícia S T Veras
Journal:  BMC Microbiol       Date:  2012-02-09       Impact factor: 3.605

10.  Transmission potential, skin inflammatory response, and parasitism of symptomatic and asymptomatic dogs with visceral leishmaniasis.

Authors:  B L A Verçosa; C M Lemos; I L Mendonça; S M M S Silva; S M de Carvalho; H Goto; F A L Costa
Journal:  BMC Vet Res       Date:  2008-11-06       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.